Stay updated with breaking news from Mathieu Chevrier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Citi analyst Mathieu Chevrier maintained a Hold rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research Report) to...
Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research Report) received a Hold rating and price target from Jarden analys...
In a report released today, Mathieu Chevrier from Citi maintained a Hold rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF &#...
Head of research and development Bill Mezzanotte said the cost of bringing a treatment like its Hemgenix to market exceeded $US1 billion ($1.49 billion)
Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q2 2023 Results Conference Call November 28, 2022 04:00 PM ET Company Participants Marcus Driller - Vice President,...